New research from Cornell scientists is exploring how human genetics impacts functions of the gut microbiome, and is expanding awareness of the role human genetics plays in shaping the microbiome.
Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer’s and some other neurodegenerative diseases, a study by Weill Cornell Medicine investigators suggests.
Hysteroscopic sterilization, a nonincisional procedure, was found to be as effective as minimally invasive laparoscopic sterilization in preventing pregnancy, but both methods had higher-than-expected failure rates, according to a new study led by an investigator at Weill Cornell Medicine.
As consumers want fewer food preservatives and less plastic waste, Cornell scientists have created a bioderived polymer that helps salad dressings and beverages last longer in the fridge.
New cancer cell research opens a new avenue for understanding how tumors spread to other tissues via metastasis, and hints at novel ways to block the spread of cancer by targeting the process.
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the Association of American Physicians.
MBA candidates in the first cohort of Cornell's new BioEntrepreneurship Initiative will collaborate with doctoral researchers in the life sciences across Cornell. The program is designed to develop startup leaders and foster innovation in the life sciences.
The newest cohort of Ph.D. candidates in Cornell Engineering's Commercialization Fellowship will spend the remainder of the year learning the skills and tools to bring their technologies to market.
Among participants who had hepatitis C and who injected drugs, those treated at a non-stigmatizing “accessible care” treatment center co-located with a syringe service program were nearly three times more likely to be cured, according to new research.
